Compare American Electric Power Company Inc (AEP) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Electric Power Company Inc vs BridgeBio Pharma Inc — how do they compare? American Electric Power Company Inc trades at $123.63 (market cap $67.28B), while BridgeBio Pharma Inc trades at $83.41 (market cap $16.36B). The key difference: American Electric Power Company Inc is far larger — about 4.1× BridgeBio Pharma Inc's market cap, and American Electric Power Company Inc pays a 3.07% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| AEP | BBIO | |
|---|---|---|
Market Cap | $67.28B | $16.36B |
Sector | Utilities | Health |
52-Week High | $138.69 | $90.17 |
52-Week Low | $106.44 | $47.29 |
Enterprise Value | $120.17B | $18.14B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
